AstraZeneca Pharma India Limited issued a postal ballot notice seeking shareholder approval to shift its registered office from Karnataka to Maharashtra.
The e-voting period is scheduled from April 12, 2026, to May 11, 2026, managed by NSDL, with results to be declared by May 13, 2026.
The proposed shift aims to enhance administrative and operational efficiency, aligning with the company's expansion footprint in Mumbai.
The resolution requires a special majority and subsequent approval from the Central Government via the Regional Director.